Guideline for the Management of Heart Failure
The evidence-based guidelines represent the important tool for the clinical practice providing the medical staff with the empirically deducted recommendations regarding the possible ways of treatment of the patients with the disease analyzed. In the case of the assignment, the focus was on the guidelines recommendations regarding beta blockers application in the medical practice of the heart failure treatment. Given that beta-blockers being a prescription-only medicine can only be prescribed by the certified healthcare professional (Nhs.uk, 2014), the thorough review of the evidence-based guidelines is needed to fully assess the possible cases for the prescription. The guidelines selected for the purpose of a current paper is ACCF/AHA Guideline for the Management of Heart Failure.
The guidelines generally encompass the variety of cases and provide a sufficient information to be applied in heart failure treatment with beta blockers application. It is beneficial to study the evidence-based guidelines so that to be able to apply its recommendations in health care settings deciding on the prescription of beta blockers. The general validity of recommendations as well as the ways to apply the evidence-based guidelines incorporating the 6 IOM in terms of patient’s best interests.Heart failure is an extremely common disease among the American population affecting more than 8 million of people and resulting in 32.8% of the cases of death that is related to cardiovascular problems as stated by American Heart Association (Roger et al., 2012).
Given the generally positive outcomes achieved by prescribing the beta blockers to the patients with heart failure, the representation of the issue in the evidence-based guideline was chosen for the selection. Beta blockers are claimed to be extremely beneficial for the patients with heart failure being able “to reverse the neurohumoral effects of the sympathetic nervous system, with ensuing prognostic and symptomatic benefits, and different societies have thus included them in guidelines for management of heart failure” (Chatterjee et al., 2013).
Beta blockers, especially of adrenergic type, demonstrate positive outcomes in reducing mortality rates, improving the symptoms of heart failure and controlling ventricular rate especially in the case of patients who have long suffered from the chronic HF as outlined in Bristow’s paper (2011). The afore outlined positive effects of beta blockers application in patients’ treatment, as well as the scale of the spread of heart failure cases among the U.S. population, were the primary reason for selecting the topic. Application of beta blockers even though might be effective and beneficial for patients’ well-being requires that the nursing or other certified healthcare specialist takes into account all the possible exceptions such as prescription of beta blockers to patients who previously took the ACE inhibitors (Yancy et al., 2013).
Beta-blockers create the additional risk factors for the patients and need the patient-centered personal approach which makes the Evidenced Based guideline selected for the analysis rather suitable and favorable to an application in the healthcare practice area.Qaseem et al. …